ADGM
Adagio Medical Holdings, Inc.
Price Chart
Latest Quote
$1.03
Current Price| Previous Close | $1.00 |
| Open | $1.00 |
| Day High | $1.08 |
| Day Low | $0.99 |
| Volume | 57,262 |
Stock Information
| Shares Outstanding | 21.18M |
| Total Debt | $21.97M |
| Cash Equivalents | $4.67M |
| Revenue | $137K |
| Net Income | $-79.15M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $21.82M |
| EPS (TTM) | $-2.35 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 13/42| Debt to Equity | 0.82 |
| Debt to Earnings | -16.17 |
| Current Ratio | 3.27 |
| Quick Ratio | 2.66 |
| Avg Revenue Growth | 3.70% |
| Profit Margin | -12715.33% |
| Return on Equity | -191.57% |
| Avg FCF Growth | 8.77% |
| FCF Yield | -119.15% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $1.03 | 57,262 |
| 2026-01-30 | $1.00 | 44,800 |
| 2026-01-29 | $1.00 | 64,400 |
| 2026-01-28 | $1.00 | 96,800 |
| 2026-01-27 | $1.00 | 49,300 |
| 2026-01-26 | $1.03 | 56,300 |
| 2026-01-23 | $1.08 | 149,700 |
| 2026-01-22 | $0.93 | 44,200 |
| 2026-01-21 | $0.88 | 25,000 |
| 2026-01-20 | $0.87 | 81,600 |
| 2026-01-16 | $0.91 | 31,600 |
| 2026-01-15 | $0.93 | 84,400 |
| 2026-01-14 | $0.88 | 123,600 |
| 2026-01-13 | $0.88 | 64,600 |
| 2026-01-12 | $0.94 | 41,800 |
| 2026-01-09 | $0.97 | 80,700 |
| 2026-01-08 | $0.95 | 497,600 |
| 2026-01-07 | $0.94 | 301,500 |
| 2026-01-06 | $0.99 | 144,900 |
| 2026-01-05 | $1.03 | 145,700 |
About Adagio Medical Holdings, Inc.
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Income Statement (Annual)
Revenue
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Reconciled Cost Of Revenue | $1,306,000 | $875,000 | $1,158,000 |
| Cost Of Revenue | $1,306,000 | $875,000 | $1,158,000 |
| Total Revenue | $300,000 | $189,000 | $270,000 |
| Operating Revenue | $300,000 | $189,000 | $270,000 |
Expenses
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Interest Expense | $1,659,000 | $137,000 | $0 |
| Total Expenses | $28,242,000 | $24,102,000 | $20,915,000 |
| Other Income Expense | $-8,548,000 | $338,000 | $704,000 |
| Other Non Operating Income Expenses | $-8,506,000 | $338,000 | $-40,000 |
| Net Non Operating Interest Income Expense | $-1,656,000 | $-98,000 | $3,000 |
| Interest Expense Non Operating | $1,659,000 | $137,000 | $0 |
| Operating Expense | $26,936,000 | $23,227,000 | $19,757,000 |
Income & Earnings
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Net Interest Income | $-1,656,000 | $-98,000 | $3,000 |
| Interest Income | $3,000 | $39,000 | $3,000 |
| Normalized Income | $-38,104,000 | $-23,673,000 | $-20,682,000 |
| Net Income From Continuing And Discontinued Operation | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Total Operating Income As Reported | $-27,942,000 | $-23,913,000 | $-20,645,000 |
| Net Income Common Stockholders | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Net Income | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Net Income Including Noncontrolling Interests | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Net Income Continuous Operations | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Pretax Income | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Special Income Charges | $-8,486,000 | $0 | $744,000 |
| Interest Income Non Operating | $3,000 | $39,000 | $3,000 |
| Operating Income | $-27,942,000 | $-23,913,000 | $-20,645,000 |
| Gross Profit | $-1,006,000 | $-686,000 | $-888,000 |
Per Share Metrics
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Diluted EPS | $-2.85 | $-1.77 | $-1.49 |
| Basic EPS | $-2.85 | $-1.77 | $-1.49 |
Other
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-35,913,000 | $-23,041,000 | $-20,346,000 |
| Total Unusual Items | $-42,000 | $0 | $744,000 |
| Total Unusual Items Excluding Goodwill | $-42,000 | $0 | $744,000 |
| Reconciled Depreciation | $532,000 | $495,000 | $336,000 |
| EBITDA (Bullshit earnings) | $-35,955,000 | $-23,041,000 | $-19,602,000 |
| EBIT | $-36,487,000 | $-23,536,000 | $-19,938,000 |
| Diluted Average Shares | $13,387,636 | $13,387,636 | $13,387,636 |
| Basic Average Shares | $13,387,636 | $13,387,636 | $13,387,636 |
| Diluted NI Availto Com Stockholders | $-38,146,000 | $-23,673,000 | $-19,938,000 |
| Other Special Charges | $8,486,000 | - | $-744,000 |
| Gain On Sale Of Security | $-42,000 | - | - |
| Research And Development | $15,399,000 | $17,855,000 | $15,355,000 |
| Selling General And Administration | $11,537,000 | $5,372,000 | $4,402,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-1,024,000 | $-132,023,000 | $-95,877,000 | $-72,618,000 |
| Total Assets | $48,448,000 | $6,825,000 | $8,697,000 | $21,444,000 |
| Total Non Current Assets | $23,099,000 | $1,640,000 | $1,965,000 | $1,720,000 |
| Other Non Current Assets | $14,000 | $23,000 | $26,000 | $22,000 |
| Goodwill And Other Intangible Assets | $20,936,000 | $0 | - | - |
| Other Intangible Assets | $6,969,000 | - | - | - |
| Current Assets | $25,349,000 | $5,185,000 | $6,732,000 | $19,724,000 |
| Other Current Assets | $222,000 | $177,000 | $527,000 | $241,000 |
| Prepaid Assets | $1,940,000 | $232,000 | $291,000 | $263,000 |
| Inventory | $2,566,000 | $3,322,000 | $367,000 | $334,000 |
| Receivables | $35,000 | $71,000 | $0 | $33,000 |
| Accounts Receivable | $35,000 | $71,000 | $0 | $33,000 |
| Cash Cash Equivalents And Short Term Investments | $20,586,000 | $1,383,000 | $5,547,000 | $18,853,000 |
| Cash And Cash Equivalents | $20,586,000 | $1,383,000 | $5,547,000 | $18,853,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $16,265,000 | $38,399,000 | $9,797,000 | $0 |
| Long Term Debt And Capital Lease Obligation | $16,122,000 | $195,000 | $134,000 | $0 |
| Long Term Debt | $16,076,000 | $143,000 | - | - |
| Current Debt And Capital Lease Obligation | $143,000 | $38,204,000 | $9,663,000 | - |
| Net Debt | - | $36,885,000 | $3,953,000 | - |
| Current Debt | - | $38,125,000 | $9,500,000 | - |
| Other Current Borrowings | - | $38,125,000 | $9,500,000 | - |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $28,536,000 | $138,848,000 | $104,574,000 | $94,062,000 |
| Total Non Current Liabilities Net Minority Interest | $20,773,000 | $91,672,000 | $91,606,000 | $91,474,000 |
| Other Non Current Liabilities | $3,616,000 | $8,000 | $3,000 | $5,000 |
| Derivative Product Liabilities | $152,000 | $0 | - | - |
| Non Current Deferred Liabilities | $883,000 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $883,000 | $0 | - | - |
| Current Liabilities | $7,763,000 | $47,176,000 | $12,968,000 | $2,588,000 |
| Payables And Accrued Expenses | $4,998,000 | $7,328,000 | $2,076,000 | $1,745,000 |
| Payables | $2,840,000 | $3,830,000 | $1,011,000 | $578,000 |
| Accounts Payable | $2,840,000 | $3,830,000 | $1,011,000 | $578,000 |
| Other Current Liabilities | - | $78,000 | - | - |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $19,912,000 | $-132,023,000 | $-95,877,000 | $-72,618,000 |
| Total Equity Gross Minority Interest | $19,912,000 | $-132,023,000 | $-95,877,000 | $-72,618,000 |
| Stockholders Equity | $19,912,000 | $-132,023,000 | $-95,877,000 | $-72,618,000 |
| Gains Losses Not Affecting Retained Earnings | $1,000 | $17,000 | $28,000 | $4,000 |
| Other Equity Adjustments | $1,000 | $17,000 | $28,000 | $4,000 |
| Retained Earnings | $-70,586,000 | $-133,649,000 | $-97,059,000 | $-73,386,000 |
| Preferred Securities Outside Stock Equity | $0 | $91,469,000 | $91,469,000 | $91,469,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $15,198,232 | $14,535,136 | $13,387,636 | $13,387,636 |
| Share Issued | $15,198,232 | $14,535,136 | $13,387,636 | $13,387,636 |
| Tangible Book Value | $-1,024,000 | $-132,023,000 | $-95,877,000 | $-72,618,000 |
| Invested Capital | $35,988,000 | $-93,755,000 | $-86,377,000 | $-72,618,000 |
| Working Capital | $17,586,000 | $-41,991,000 | $-6,236,000 | $17,136,000 |
| Capital Lease Obligations | $189,000 | $131,000 | $297,000 | $0 |
| Total Capitalization | $35,988,000 | $-131,880,000 | $-95,877,000 | $-72,618,000 |
| Additional Paid In Capital | $90,495,000 | $1,608,000 | $1,153,000 | $763,000 |
| Capital Stock | $2,000 | $1,000 | $1,000 | $1,000 |
| Common Stock | $2,000 | $1,000 | $1,000 | $1,000 |
| Long Term Capital Lease Obligation | $46,000 | $52,000 | $134,000 | $0 |
| Current Capital Lease Obligation | $143,000 | $79,000 | $163,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,622,000 | $1,566,000 | $1,229,000 | $843,000 |
| Current Accrued Expenses | $2,158,000 | $3,498,000 | $1,065,000 | $1,167,000 |
| Goodwill | $13,967,000 | $0 | - | - |
| Net PPE | $2,149,000 | $1,617,000 | $1,939,000 | $1,698,000 |
| Accumulated Depreciation | $-2,730,000 | $-1,777,000 | $-1,240,000 | $-772,000 |
| Gross PPE | $4,879,000 | $3,394,000 | $3,179,000 | $2,470,000 |
| Leases | $306,000 | $305,000 | $303,000 | $303,000 |
| Construction In Progress | $0 | $54,000 | $54,000 | $28,000 |
| Other Properties | $3,571,000 | $1,982,000 | $1,845,000 | $255,000 |
| Machinery Furniture Equipment | $1,002,000 | $1,053,000 | $977,000 | $1,884,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $495,000 | $914,000 | $367,000 | $334,000 |
| Work In Process | $388,000 | $197,000 | $0 | - |
| Raw Materials | $1,683,000 | $2,211,000 | $0 | - |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | $-25,992,000 | $-22,914,000 | $-20,579,000 |
Operating Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Operating Cash Flow | $-25,652,000 | $-22,412,000 | $-19,307,000 |
| Cash Flow From Continuing Operating Activities | $-25,652,000 | $-22,412,000 | $-19,307,000 |
| Operating Gains Losses | $45,000 | - | $-744,000 |
Investing Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Capital Expenditure | $-340,000 | $-502,000 | $-1,272,000 |
| Investing Cash Flow | $-340,000 | $-500,000 | $-1,272,000 |
| Cash Flow From Continuing Investing Activities | $-340,000 | $-500,000 | $-1,272,000 |
Financing Activities
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Financing Cash Flow | $21,875,000 | $9,525,000 | $130,000 |
| Cash Flow From Continuing Financing Activities | $21,875,000 | $9,525,000 | $130,000 |
Other
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Repayment Of Debt | $-1,143,000 | $0 | - |
| Issuance Of Debt | $23,000,000 | $9,500,000 | $0 |
| Interest Paid Supplemental Data | $208,000 | $0 | - |
| End Cash Position | $1,383,000 | $5,547,000 | $18,853,000 |
| Beginning Cash Position | $5,547,000 | $18,853,000 | $39,233,000 |
| Effect Of Exchange Rate Changes | $-47,000 | $81,000 | $69,000 |
| Changes In Cash | $-4,117,000 | $-13,387,000 | $-20,449,000 |
| Proceeds From Stock Option Exercised | $18,000 | $25,000 | $130,000 |
| Net Issuance Payments Of Debt | $21,857,000 | $9,500,000 | $0 |
| Net Short Term Debt Issuance | $20,000,000 | $9,500,000 | $0 |
| Short Term Debt Issuance | $20,000,000 | $9,500,000 | $0 |
| Net Long Term Debt Issuance | $21,857,000 | $9,500,000 | $0 |
| Long Term Debt Payments | $-1,143,000 | $0 | - |
| Long Term Debt Issuance | $23,000,000 | $9,500,000 | $0 |
| Net Intangibles Purchase And Sale | $-7,000 | $-10,000 | $-14,000 |
| Purchase Of Intangibles | $-7,000 | $-10,000 | $-14,000 |
| Net PPE Purchase And Sale | $-333,000 | $-490,000 | $-1,258,000 |
| Sale Of PPE | $0 | $2,000 | $0 |
| Purchase Of PPE | $-333,000 | $-492,000 | $-1,258,000 |
| Change In Working Capital | $2,789,000 | $330,000 | $579,000 |
| Change In Other Current Liabilities | $-161,000 | $-148,000 | $-15,000 |
| Change In Payables And Accrued Expense | $5,586,000 | $730,000 | $1,071,000 |
| Change In Accrued Expense | $2,765,000 | $294,000 | $792,000 |
| Change In Payable | $2,821,000 | $436,000 | $279,000 |
| Change In Account Payable | $2,821,000 | $436,000 | $279,000 |
| Change In Prepaid Assets | $410,000 | $-320,000 | $-44,000 |
| Change In Inventory | $-2,976,000 | $35,000 | $-473,000 |
| Change In Receivables | $-70,000 | $33,000 | $40,000 |
| Changes In Account Receivables | $-70,000 | $33,000 | $40,000 |
| Other Non Cash Items | $8,661,000 | $147,000 | - |
| Stock Based Compensation | $442,000 | $365,000 | $339,000 |
| Asset Impairment Charge | $25,000 | $-76,000 | $121,000 |
| Depreciation Amortization Depletion | $532,000 | $495,000 | $336,000 |
| Depreciation And Amortization | $532,000 | $495,000 | $336,000 |
| Gain Loss On Investment Securities | $42,000 | - | - |
| Gain Loss On Sale Of PPE | $3,000 | $0 | - |
| Net Income From Continuing Operations | $-38,146,000 | $-23,673,000 | $-19,938,000 |